Xylem Inc. XYL

102.63 (0.03) (0.03%) as of 25 Sep
Market cap
$24.2B
P/E
24.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

8.69% 8.65% 9.00% 9.47%
ROA
5.69% 5.61% 5.85% 5.90%
ROIC
5.93% 6.39% 6.38% 6.84%
Return on Tangible Assets
28.61% 32.51% 40.44% 35.88%
Average Days of Receivables
73.99 71.06 72.11 74.99
Free Cash Flow per Share
3.86 3.81 4.03 4.16
Free Cash Flow
941.00 927.00 979.00 983.00
Capital Expenditures
(332.00) (314.00) (337.00) (318.00)
Piotroski F-Score
8.00 7.00 7.00 5.00
Other line items
Cash ROIC
8.86% 8.32% 9.59% 8.90%
Accounts Receivable Turnover
5.07 5.27 5.14 4.92
Accounts Payable Turnover
5.79 5.51 5.79 5.38
Inventory Turnover
5.17 5.62 5.55 5.31
Average Days of Payables
64.31 66.50 63.37 66.68
Days of Inventory on Hand
68.76 64.53 64.81 66.88
Tax Rate
(0.21) (0.20) (0.20) (0.21)
Research and Development Expense of Revenue
2.52% 2.50% 2.49% 2.49%
Selling, General and Administrative Expense of Revenue
21.86% 21.28% 21.28% 21.20%
Share Based Compensation of Revenue
0.56% 0.59% 0.59% 0.58%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.34 1.30 1.34 1.28
Depreciation/Fixed assets
0.50 0.50 0.50 0.48
Capex/Depreciation
(0.58) (0.55) (0.59) (0.56)
Revenue per Share
36.53 37.12 37.44 38.62
Operating CF per Share
5.23 5.10 5.42 5.51
Capex per Share
(1.36) (1.29) (1.39) (1.35)
Capex to Sales
0.04 0.03 0.04 0.03
Net Profit Margin
10.66% 10.59% 10.79% 11.15%

Fold the line items

Columns are period end dates